
Brad D Constant MD
@braddconstantmd
Pediatric Gastroenterologist at Children's Hospital of Colorado. Comparative Effectiveness Research and Advocacy. Crohn’s Disease patient since ‘97.
ID: 1396488346273148930
23-05-2021 15:29:07
26 Tweet
119 Followers
136 Following

We are proud to announce that Children's Hospital Colorado has been ranked No.1 in the nation by U.S. News & World Report for #Gastroenterology & GI Surgery for the 2nd year in a row! ✨ health.usnews.com/best-hospitals… #BestHospitals #Pediatrics #PedsGI


Important work from my friend and fellow IBD fellow Ruben Colman, MD, PhD describing the relationship between antibodies to infliximab and dose intensification! Congrats!

Per Frank I Scott, MD MSCE, #PriorAuthorizations lead to delays in starting disease modifying therapies --> which adversely impact patient outcomes in #IBD. Wow... Walid Gellad may have something to say about this - suspect not isolated to #IBD...


Thank you @aap_pediatrics for these thoughtful pieces demonstrating how #PriorAuthorizations impact patients across all of #Pediatrics! Lewis First publications.aap.org/journal-blogs/… Cara Coleman bit.ly/3LXd6KG





NEW PAPER I was challenged by Chris Morley, PhD to write a 1000-word paper about a tweet. It was fun to do, and hopefully useful to some of you Open acces 👉 journals.stfm.org/primer/2022/va…


In this retrospective review, Brad D Constant MD et al studied the use of tofacitinib as salvage therapy in children with steroid and biologic-refractory #ulcerativecolitis with >50% remaining colectomy-free after 90 days. bit.ly/3VPi4NX bit.ly/3VPi4NX

Great preliminary work by Brad D Constant MD and colleagues, who are collaborating to better understand the safety and efficacy of antiTNFs in internally penetrating pediatric Crohn’s disease #CCCongress23


cnn.com/2023/03/10/hea… Great article by Lauren Sausser showing all the ways prior authorizations take medical decision making out of doctors’ and patients’ hands, disrupt care, and lead to real patient harm. This system need to change.